Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-tesla mr-linac

HIGHLIGHTS

• who: Lin-Rui Gao and collaborators from the Amsterdam University Medical Center, France have published the research: Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac, in the Journal: (JOURNAL)
• what: The aim of this study was to estimate the delivered dose for targets and OARs by dosimetry analysis based on high resolution 3D-MR aquisitions, including pre-, position verification (PV-), beamon (Bn-), and post-3D-MR scans, of each adaptive RT session for PCa patients treated on 1.5-T MR-linac. For this . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.